A Prospective and Retrospective, Observational Multicentre Ibalizumab Study of Efficacy (PROMISE)

19/02/2021
23/04/2024
EU PAS number:
EUPAS39579
Study
Ongoing

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

Prospective patient-based data collection
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No